Cite
Pomerantz M, Lichtenstein DA, Niesvizky-Kogan I, et al. Nivolumab and Ipilimumab-induced Acute Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report. J Immunother. 2019;42(9):348-349doi: 10.1097/CJI.0000000000000285.
Pomerantz, M., Lichtenstein, D. A., Niesvizky-Kogan, I., Sohal, R., Leibovitch, J., & Basnet, A. (2019). Nivolumab and Ipilimumab-induced Acute Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report. Journal of immunotherapy (Hagerstown, Md. : 1997), 42(9), 348-349. https://doi.org/10.1097/CJI.0000000000000285
Pomerantz, Madison, et al. "Nivolumab and Ipilimumab-induced Acute Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report." Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 42,9 (2019): 348-349. doi: https://doi.org/10.1097/CJI.0000000000000285
Pomerantz M, Lichtenstein DA, Niesvizky-Kogan I, Sohal R, Leibovitch J, Basnet A. Nivolumab and Ipilimumab-induced Acute Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report. J Immunother. 2019 Nov/Dec;42(9):348-349. doi: 10.1097/CJI.0000000000000285. PMID: 31261166.
Copy
Download .nbib